亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)氫氯噻嗪廠家CAS編號(hào): 58-93-5

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市預(yù)售,付款后7天內(nèi)
型號(hào) 58-93-5
過期 長(zhǎng)期有效
更新 2011-01-30 16:15
 

湖北康寶泰精細(xì)化工有限公司(銷售部)

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明


氫氯噻嗪

產(chǎn)品類別: 醫(yī)藥原料
【拉丁名】Hydrochlorothiazide
 產(chǎn)品含量: 99%
化學(xué)式: C7H8ClN3O4S2
CAS編號(hào): 58-93-5
質(zhì)量標(biāo)準(zhǔn): USP27
包裝規(guī)格: 25公斤/紙板桶
【作用和用途】
主要抑制髓袢升支皮質(zhì)部對(duì)Na+和Cl-的重吸收,使腎臟對(duì)氯化鈉的排泄增加而產(chǎn)生利尿作用,是一種中效利尿藥
本品有降壓作用,可以與其他降壓藥物配合作用。
本品還有抗利尿的作用,可用于治療尿崩癥。

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)西洛他唑廠家CAS號(hào): 73963-72-1 供應(yīng)托拉塞米廠家CAS號(hào):56211-40-6 供應(yīng)鹽酸奧昔布寧廠家CAS號(hào):1508-65-2 供應(yīng)呋塞米廠家CAS號(hào):54-31-9 供應(yīng)依他尼酸廠家CAS號(hào):58-54-8 供應(yīng)三氯噻嗪廠家CAS號(hào):133-67-5 供應(yīng)鹽酸可樂定廠家CAS編號(hào): 4205-91-8 供應(yīng)尼群地平廠家CASNO :39562-70-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |